Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
The International Journal of Biological Markers|June 28, 2018
Coexistence of three EGFR mutations in an NSCLC patient: A brief reportFrancesca Belardinilli, Angela Gradilone, Alain Gelibter, et al.
Plos One|November 19, 2015
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC CellsDario Presutti, Simonetta Santini, Beatrice Cardinali, et al.
Bioorganic & Medicinal Chemistry|February 29, 2008
Synthesis and DNA-cleaving activity of lactenediynes conjugated with DNA-complexing moietiesLuca Banfi, Andrea Basso, Elisabetta Bevilacqua, et al.
Plos One|November 16, 2012
Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cellsVeronica Veschi, Marialaura Petroni, Beatrice Cardinali, et al.
Molecular Cancer Therapeutics|October 28, 2003
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analoguesP James Scrivens, Moulay A Alaoui-Jamali, Giuseppe Giannini, et al.
Chemmedchem|October 13, 2009
Azetidinones as zinc-binding groups to design selective HDAC8 inhibitorsPaola Galletti, Arianna Quintavalla, Caterina Ventrici, et al.
Cancers|July 29, 2023
The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and BeyondMarialaura Petroni, Veronica La Monica, Francesca Fabretti, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitorsGiuseppe Giannini, Mauro Marzi, Maria Di Marzo, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitorsGiuseppe Giannini, Mauro Marzi, Riccardo Pezzi, et al.
Cancers|January 10, 2019
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal CancerCristina Raimondi, Chiara Nicolazzo, Francesca Belardinilli, et al.
Pageof 20